World Pharma Today

Healthcare systems can collapse overnight, particularly in natural disasters and conflicts that force communities to flee. In such moments, speed matters as much as skill. People need...

Husky Technologies™, a global leader in precision injection molding solutions and services is collaborating with SEM Plastik San. ve Tic. A.Ş., under its SEM BIOTECH division, to...

This article includes: Expanding the Role of Mail-Order Pharmacies Overcoming Operational Hurdles With Error-Reduction Systems Examining the Key Pillars of Pharmacy Automation Transformation Capsa Healthcare: A Blueprint...

Building a compelling Series B case in biopharma goes well beyond efficacy data and market size projections. Sophisticated investors are increasingly focused on CMC risk, licensing obligations, and the defensibility of your manufacturing timeline. This article breaks down what the financial model behind a strong Series B actually looks like and what quietly kills deals that should have worked.

Ask any experienced biopharma program manager what derails an IND filing most often, and the answer is rarely surprising: it is CMC. Not insufficient efficacy data, not toxicology surprises CMC. This article examines why Chemistry, Manufacturing, and Controls continues to be the most underestimated risk in early drug development, and what program leaders can do about it.

In pharmaceutical manufacturing, you operate in an environment where precision, traceability and compliance define every decision you make. That’s why choosing the right FDA-compliant packaging equipment and...

When you decide to buy regulatory compliance certification online, you’re stepping into a space that demands careful evaluation. You’re making a decision that can directly influence your...

Strategic early-stage planning and rigorous regulatory readiness serve as the foundation for accelerating pharmaceutical timelines and optimizing long-term R&D efficiency.

Optimization of clinical trial protocols through innovative designs and strategic endpoint selection directly accelerates drug development speed and improves operational reliability.

Integrating comprehensive analytics and real-world data into clinical planning allows pharmaceutical companies to optimize trial design and significantly improve patient outcomes.